| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 32,801 | 28,736 | 28,692 | 29,566 | | Cost of Revenue | 23,471 | 20,600 | 21,286 | 21,676 | | | Gross Profit | 9,330 | 8,136 | 7,406 | 7,890 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,013 | 6,440 | 6,093 | 6,748 | | Non Recurring |
-
| 4 | 31 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,301 | 1,692 | 1,282 | 1,142 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21 | 204 | (69) | (67) | | Earnings Before Interest And Taxes | 1,302 | 3,530 | (421) | 1,112 | | Interest Expense | (723) | 327 | 396 | 382 | | Income Before Tax | 2,025 | 3,203 | (817) | 730 | | Income Tax Expense | 830 | 638 | 328 | 401 | | Minority Interest | (70) | (79) | 51 | (32) | | | | Net Income From Continuing Ops | 1,125 | 852 | 540 | 297 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 310 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,125 | 852 | 540 | 607 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,125 | $852 | $540 | $607 |
|
0.11% Nasdaq 
0.01%
Income Statement
